BiotechTube

Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + Placebo

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Common Cold

Conditions

Common Cold, Pharyngitis, Tonsillitis

Trial Timeline

Nov 1, 2003 → Mar 1, 2005

NCT ID
NCT01465009

About Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + Placebo

Acetylsalicylic acid (Aspirin, BAYE4465) + Paracetamol + Placebo is a approved stage product being developed by Bayer for Common Cold. The current trial status is completed. This product is registered under clinical trial identifier NCT01465009. Target conditions include Common Cold, Pharyngitis, Tonsillitis.

What happened to similar drugs?

4 of 16 similar drugs in Common Cold were approved

Approved (4) Terminated (3) Active (10)
✅Pseudoephedrine/ParacetamolJohnson & JohnsonApproved
✅Dextromethorphan + PlaceboNovartisApproved
✅VivaglobinCSLApproved
✅Aspirin (Acetylsalicylic acid, BAYE4465) + PlaceboBayerApproved
🔄Lidocaine 8mg + CPC 2mg + Lidocaine 1mg + CPC 2mgNovartisPhase 3
🔄XylometazolineNovartisPhase 3
❌Advil Congestion Relief + Advil Allergy and Congestion Relief + ParacetamolPfizerPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
12
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01465009ApprovedCompleted

Competing Products

20 competing products in Common Cold

See all competitors
ProductCompanyStageHype Score
Nasal Glucagon + OxymetazolineEli LillyPhase 1
29
New Formulation Phenylephrine HCl + Marketed Phenylephrine HCl + PlaceboJohnson & JohnsonPhase 2
27
Pseudoephedrine/ParacetamolJohnson & JohnsonApproved
43
Zostavax®MerckPre-clinical
18
Lidocaine 8mg + CPC 2mg + Lidocaine 1mg + CPC 2mgNovartisPhase 3
40
CDZ173NovartisPhase 2/3
38
Dextromethorphan + PlaceboNovartisApproved
35
XylometazolineNovartisPhase 3
40
N-acetylcysteine + PlaceboNovartisPhase 2
35
Advil Congestion Relief + Advil Allergy and Congestion Relief + ParacetamolPfizerPhase 3
32
pseudoephedrine hydrochloride 30 mg tablets + Placebo tabletsPfizerPhase 3
40
gammaglobulinCSLPre-clinical
26
Human Normal Immunoglobulin for Subcutaneous Administration (IGSC)CSLPhase 3
40
VivaglobinCSLApproved
43
Aspirin (Acetylsalicylic acid, BAYE4465) + PlaceboBayerApproved
40
Acetylsalicylic acid (Aspirin, BAYE4465) & Lidocain + Acetylsalicylic Acid (Aspirin, BAYE4465) + Lidocain + PlaceboBayerPhase 3
37
Acetylsalicylic Acid (Aspirin Complex, BAYE4465) + Pseudoephedrine + Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + PlaceboBayerPhase 3
37
Acetylsalicylic Acid (Aspirin, BAYE4465) + Pseudoephedrine + PlaceboBayerPhase 3
37
Acetylcysteine + Paracetamol + PhenylephrineSandoz GroupPhase 3
29
A-101Aclaris TherapeuticsPhase 3
30